Pfizer Animal Health is voluntarily recalling one lot each from its Antisedan and Dexdomitor sterile injectable solutions.
Dexdomitor is used as a sedative and analgesic in dogs and cats, as well as a preanesthetic to general anesthesia. Antisedan is used to reverse the sedative and analgesic effects of Dexdomitor.
Pfizer announced Sept. 16, 2011 that the two lots may contain foreign particles originating from a glass vial manufacturing defect. The affected lots are lots 1399276 of Antisedan (expiration: March 2014) and 1391999 of Dexdomitor (expiration: January 2014).
According to a Pfizer news release, Pfizer and manufacturing partner Orion Corporation implemented the recall after a scientific assessment that the affected lots could result in serious negative health effects.
Customers can contact Pfizer’s Veterinary Medical Information and Product Support group with questions or for more information at 800-366-5288.
Source: Pfizer Animal Health
